ICCBS Libraries
 WELCOME TO THE ICCBS LIBRARIES CATALOG

Chapter 17: Small Molecule Vascular Disrupting Agents: Potential New Drugs for Cancer Treatment, a 2009 Update Book Title: Frontiers in Anit-Cancer Drug Discovery

By: Publication details: Netherlands Bentham-e-Books 2010Description: Page(s) 380-427LOC classification:
  • RS431.A64 F76 2010
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Date due Barcode
Book Content Book Content The National Library of Chemical Sciences, HEJ Research Institute of Chemistry (HEJ) Library QD-431.A64.F76-2010 (Browse shelf(Opens below)) Not for loan 6618-C17
Browsing The National Library of Chemical Sciences, HEJ Research Institute of Chemistry (HEJ) Library shelves Close shelf browser (Hides shelf browser)
No cover image available No cover image available No cover image available No cover image available No cover image available No cover image available No cover image available
QD-431.A64.F76-2010 Chapter 14: Cetuximab: Its Use in Combination with Radiation Therapy and Chemotherapy in the Multimodality Treatment of Head and Neck Cancers | Book Title: Frontiers in Anit-Cancer Drug Discovery QD-431.A64.F76-2010 Chapter 15: Platinum-Based Anticancer Agents | Book Title: Frontiers in Anit-Cancer Drug Discovery QD-431.A64.F76-2010 Chapter 16: c-Myc and Downstream Targets in the Pathogenesis and Treatment of Cancer | Book Title: Frontiers in Anit-Cancer Drug Discovery QD-431.A64.F76-2010 Chapter 17: Small Molecule Vascular Disrupting Agents: Potential New Drugs for Cancer Treatment, a 2009 Update | Book Title: Frontiers in Anit-Cancer Drug Discovery QD-431.A64.F76-2010 Chapter 18: Developments in Targeted Therapy of Advanced Gastrointestinal Stromal Tumors | Book Title: Frontiers in Anit-Cancer Drug Discovery QD-431.A64.F76-2010 Chapter 19: Therapeutic Transfer of DNA Encoding Adenoviral ElA | Book Title: Frontiers in Anit-Cancer Drug Discovery RS-431.A64.F76-2010 Chapter 2: Thymidine Phoshorylase/Platelet-Derived Endothelial Cell Growth Factor as a Target for Capecitabine: form Biology to the Bedside | Book Title: Frontiers in Anit-Cancer Drug Discovery